Shionogi

Photo: Photo Credit: James Gathany Content Providers: CDC/ Douglas / Wikimedia Commons, Public domain

Shionogi agrees to buy rare-disease drugmaker IntraBio for $2 billion

Shionogi is paying $2 billion in cash for a privately held biotech whose only product, Aqneursa, brought in about $68 million last year and won a second FDA approval less than three weeks before the deal.